Video

Survey of actionable driver mutations KRAS and EGFR in non–small cell lung cancer

Molecularly targeted therapies have advanced treatment for certain cancers, such as lung cancer with specific EGFR or KRAS mutations. However, oftentimes the tumor becomes eventually treatment resistant.